Financing - Health Technology Insights

P3 Health Partners Issues 2025 Guidance, Proposes Financing

February 14, 2025

Company provides preliminary 2025 guidance and advance notification of a proposed financing transaction to provide a $30 million unsecured promissory note. P3 Health Partners Inc.,

Northwest Biotherapeutics Announces $5 Million Convertible Note Financing

Northwest Biotherapeutics Secures $5M Convertible Note and $50M Facility

January 3, 2025

Northwest Biotherapeutics, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it entered into a $5 million convertible Promissory Note

Categories

Tag: Financing

P3 Health Partners Issues 2025 Guidance, Proposes Financing

Northwest Biotherapeutics Secures $5M Convertible Note and $50M Facility

Share With

Recent Posts

Modella AI Announces Agreement to Accelerate AI-Driven Oncology Clinical Development

Microsoft’s Email Encryption Behavior May Violate HIPAA, New Paubox Report Warns

Britt Vitalone Joins Align Technology Board of Directors

Nuclear Care Partners Backs Bipartisan Bill for Energy Workers’ Care

Lake Chelan Health Enters into Prime Vendor Agreement with Medline

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands